Amanote Research
Register
Sign In
192. Neutralizing Antibodies Against AAV Capsids in Patients With Mut Methylmalonic Acidemia (MMA)
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35205-4
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Vitamin B12-Unresponsive Methylmalonic Acidemia Type Mut-
280. A Partial Deficiency Model of MUT Methylmalonic Acidemia (MMA) Displays Diet Inducible Disease and Sensitivity to Acetaminophen (APAP)
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
135. Cell Autonomy in Methylmalonic Acidemia (MMA): Implications for Gene and Cell Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Detailed Analysis of Methylmalonic Acid Kinetics During Hemodialysis and After Combined Liver/Kidney Transplantation in a Patient With Mut 0 Methylmalonic Acidemia
Journal of Inherited Metabolic Disease
Genetics
The Proteome of Methylmalonic Acidemia (MMA): The Elucidation of Altered Pathways in Patient Livers
Molecular BioSystems
Biotechnology
Molecular Biology
AB056. Biochemical and Molecular Investigation of Patients With Methylmalonic Acidemia in Thailand
Annals of Translational Medicine
Medicine
Vitamin B12-Unresponsive Methylmalonic Acidemia
Methylmalonic Acidemia: Can Treatment Be Improved?
Journal of Nutritional Therapeutics
Review: Neutralizing Antibodies Against Interferon-Beta
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
